Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Coordination Pharmaceuticals, Inc.
NYU Langone Health
National Cancer Institute (NCI)
Ann & Robert H Lurie Children's Hospital of Chicago
Maastricht University Medical Center
Barbara Ann Karmanos Cancer Institute
University of Washington
Basilea Pharmaceutica
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Hoosier Cancer Research Network
Northwestern University
University of Nebraska
University of Washington
University of California, Davis
M.D. Anderson Cancer Center
Cancer Trials Ireland
Pfizer
Medical College of Wisconsin
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Grupo de Investigación Clínica en Oncología Radioterapia
Spectrum Pharmaceuticals, Inc
Oslo University Hospital
Brown University
Kantonsspital Graubuenden
Baylor College of Medicine
University of Texas Southwestern Medical Center
Weill Medical College of Cornell University
The University of Texas Health Science Center at San Antonio
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Scripps Health
Stanford University
Oslo University Hospital
HCA International Limited
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Balgrist University Hospital